These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2466366)

  • 1. Cross-neutralization of genetic reassortants of bluetongue virus serotypes 20 and 21.
    Cowley JA; Gorman BM
    Vet Microbiol; 1989 Jan; 19(1):37-51. PubMed ID: 2466366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the roles of bluetongue virus outer capsid proteins VP2 and VP5 in determination of virus serotype.
    Mertens PP; Pedley S; Cowley J; Burroughs JN; Corteyn AH; Jeggo MH; Jennings DM; Gorman BM
    Virology; 1989 Jun; 170(2):561-5. PubMed ID: 2543130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformation of the VP2 protein of bluetongue virus (BTV) determines the involvement in virus neutralization of highly conserved epitopes within the BTV serogroup.
    White JR; Eaton BT
    J Gen Virol; 1990 Jun; 71 ( Pt 6)():1325-32. PubMed ID: 1693664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a neutralizing epitope shared by bluetongue virus serotypes 2 and 13.
    Ristow S; Leendersten L; Gorham J; Yilma T
    J Virol; 1988 Jul; 62(7):2502-4. PubMed ID: 2453681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies to bluetongue virus define two neutralizing epitopes and a hemagglutinating epitope.
    Mecham JO; Jochim MM
    Viral Immunol; 1990; 3(2):161-70. PubMed ID: 1694430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of serotype specificity and protein structure of the five U.S. serotypes of bluetongue virus.
    Mecham JO; Dean VC; Jochim MM
    J Gen Virol; 1986 Dec; 67 ( Pt 12)():2617-24. PubMed ID: 2432162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of recombinant baculoviruses expressing the outer capsid protein VP2 of five BTV serotypes and the induction of neutralizing antibodies to homologous and heterologous BTV serotypes.
    Urakawa T; French TJ; Adachi Y; Fukusho A; LeBlois H; Flamand M; Mertens P; Roy P
    Virus Res; 1994 Feb; 31(2):149-61. PubMed ID: 8178571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing epitopes of the serotypes of bluetongue virus present in the United States.
    Rossitto PV; MacLachlan NJ
    J Gen Virol; 1992 Aug; 73 ( Pt 8)():1947-52. PubMed ID: 1379625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of four distinct neutralizing epitopes on bluetongue virus serotype 10 using neutralizing monoclonal antibodies and neutralization-escape variants.
    Heidner HW; Rossitto PV; MacLachlan NJ
    Virology; 1990 Jun; 176(2):658-61. PubMed ID: 1693250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bluetongue virus serotype 17 sequence variation associated with neutralization.
    Wilson WC; Bernard KA; Israel BA; Mecham JO
    DNA Seq; 2008 Jun; 19(3):237-40. PubMed ID: 17852347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody analysis of serotype-restricted and unrestricted bluetongue viral antigenic determinants.
    Appleton JA; Letchworth GJ
    Virology; 1983 Jan; 124(2):286-99. PubMed ID: 6186076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes.
    Fay PC; Mohd Jaafar F; Batten C; Attoui H; Saunders K; Lomonossoff GP; Reid E; Horton D; Maan S; Haig D; Daly JM; Mertens PPC
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential serologic responses to reassortant bluetongue viruses recovered from a bull.
    Maia MS; Osburn BI
    Arch Virol; 1993; 128(3-4):345-56. PubMed ID: 8382039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homotypic and heterotypic neutralization determinants of bluetongue virus serotype 17.
    Pierce CM; Rossitto PV; MacLachlan NJ
    Virology; 1995 May; 209(1):263-7. PubMed ID: 7538255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A synthetic biology approach for a vaccine platform against known and newly emerging serotypes of bluetongue virus.
    Nunes SF; Hamers C; Ratinier M; Shaw A; Brunet S; Hudelet P; Palmarini M
    J Virol; 2014 Nov; 88(21):12222-32. PubMed ID: 25142610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassortment between two serologically unrelated bluetongue virus strains is flexible and can involve any genome segment.
    Shaw AE; Ratinier M; Nunes SF; Nomikou K; Caporale M; Golder M; Allan K; Hamers C; Hudelet P; Zientara S; Breard E; Mertens P; Palmarini M
    J Virol; 2013 Jan; 87(1):543-57. PubMed ID: 23097432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of the neutralization antigen VP2 of bluetongue virus serotype 10 using a baculovirus expression vector.
    Inumaru S; Roy P
    Virology; 1987 Apr; 157(2):472-9. PubMed ID: 3029984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in the bluetongue virus neutralization protein VP2.
    Fukusho A; Ritter GD; Roy P
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2967-73. PubMed ID: 2824673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.